BWL
JAZZ icon

Bogart Wealth LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bogart Wealth LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51K Sell
8
-542
-99% -$94.7K ﹤0.01% 1335
2025
Q4 		$93.5K Buy
550
+546
+13,650% +$83.7K ﹤0.01% 349
2025
Q3 		$527 Hold
4
– – ﹤0.01% 1411
2025
Q2 		$424 Hold
4
– – ﹤0.01% 1377
2025
Q1 		$497 Buy
+4
New +$522 ﹤0.01% 1282

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bogart Wealth LLC's JAZZ Position: Q1 2026 in Review

Bogart Wealth LLC reduced its Jazz Pharmaceuticals (JAZZ) stake by 99% in Q1 2026, selling an estimated $94.7K and leaving 8 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1335.

Bogart Wealth LLC first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. The position peaked at $93.5K in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Bogart Wealth LLC held 8 shares of Jazz Pharmaceuticals worth $1.51K as of Q1 2026.
  • Bogart Wealth LLC sold 542 Jazz Pharmaceuticals shares in Q1 2026, an estimated $94.7K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1335 holding.
  • Bogart Wealth LLC first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Bogart Wealth LLC's Jazz Pharmaceuticals position peaked at $93.5K in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.